Full Coverage

Teva Pharmaceutical Industries presents at Goldman Sachs conference

Teva, Amneal rated Buy, Viatris Neutral as Goldman Sachs reviews generics space

16 days ago

By Dulan Lokuwithana

Teva Pharmaceutical To Present At Jefferies Global Healthcare Conference; Webcast At 9:20 AM ET

18 days ago

Investing.com Australia

Goldman Sachs initiates coverage on generic drugmakers, sees upside in Teva and Am

15 days ago

By Pratyush Thakur

Goldman Sachs Starts Teva Pharma (TEVA ) at Buy

16 days ago

Transcript : Teva Pharmaceutical Industries Limited Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 09

18 days ago

Goldman Sachs Initiates Coverage on Teva Pharmaceutical (TEVA) | TEVA Stock News

16 days ago

Goldman Sachs Bullish On Branded Drug Upside At Teva: What About Viatris?

16 days ago

By Vandana Singh

Teva at Jefferies Healthcare: Strategic Growth and Innovation

18 days ago

Search

Clear search

Close search

Google apps

Main menu